Rocket Pharmaceuticals (NASDAQ:RCKT) just reported results for the first quarter of 2024.
- Rocket Pharmaceuticals reported earnings per share of -66 cents. This was above the analyst estimate for EPS of -69 cents.
- The company did not report any revenue for the quarter.